Developments in Pharmaceutical and Biotech Patent Law 2017

Front Matter
Faculty Bios
Table of Contents
Chapter 1. Ch. 14: Biologic and Biosimilar Drug Products, Practising Law Institute, Pharmaceutical and Biotech Patent Law (Prepublication Revision) (August 2017)
Chapter 2. Excerpt from Ch. 5: Patentability, Practising Law Institute, Pharmaceutical and Biotech Patent Law § 5:4.5 [C] (November 2016)
Chapter 3. Excerpt from Ch. 7: Types of Biological and Pharmaceutical Patents, Practising Law Institute, Pharmaceutical and Biotech Patent Law § 7:7 (November 2016)
Chapter 4. Ethical Issues Confronting Life Sciences Patent Lawyers
Chapter 5. The Changing Scope of Prior Art: What’s New, What’s In, What’s Out (Substantive Outline)
Chapter 6. Strategic Approaches to the Interplay Between Hatch-Waxman Litigation and Inter Partes Review
Chapter 7. Section 101: Patentable Subject Matter in the Aftermath of Myriad and Mayo
Index